Psychiatric symptoms in glioma patients: From diagnosis to management

Neuropsychiatric Disease and Treatment

Volumn 11, Issue , 2015, Pages 1413-1420

  Boele, Florien W ^a   Rooney, Alasdair G ^b   Grant, Robin ^b   Klein, Martin ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Glioma; Hallucinations; Mood; Personality; Psychiatry; Psychosis

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HALOPERIDOL; OLANZAPINE; RISPERIDONE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ANGER; ANXIETY DISORDER; APATHY; ARTICLE; BECK DEPRESSION INVENTORY; BEHAVIOR CHANGE; CANCER PATIENT; COGNITIVE THERAPY; DEPRESSION; EARLY DIAGNOSIS; FUNCTIONAL INDEPENDENCE MEASURE; GLIOMA; GRIEF; HALLUCINATION; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; IMPULSIVENESS; MANIA; MENTAL DISEASE; NEUROIMAGING; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; PATIENT EDUCATION; PATIENT HEALTH QUESTIONNAIRE 9; PATIENT REFERRAL; PERSONALITY; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOCIAL COGNITION; SUICIDAL IDEATION; SYSTEMATIC REVIEW (TOPIC); VOXEL BASED LESION SYMPTOM MAPPING;

EID: 84933496537     PISSN: None     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S65874     Document Type: Article

References (103)

1. Ho VK, Reijneveld JC, Enting RH, et al; Dutch Society for Neuro-Oncology (LWNO). Changing incidence and improved survival of gliomas. Eur J Cancer. 2014;50(13):2309-2318.
2. van den Bent MJ, Afra D, de Witte O, et al; EORTC Radiotherapy and Brain Tumor Groups and the UK Medical Research Council. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet. 2005;366(9490):985-990.
3. Ohgaki H, Kleihues P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol. 2005;64(6):479-489.
4. van den Bent MJ, Brandes AA, Taphoorn MJ, et al. Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. J Clin Oncol. 2013;31(3):344-350.
5. Stupp R, Mason WP, van den Bent MJ, et al; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups, National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987-996.
6. Cohen AL, Colman H. Glioma Biology and Molecular Markers. Current Understanding and Treatment of Gliomas. Springer; 2015:15-30.
7. Kostaras X, Cusano F, Kline GA, Roa W, Easaw J. Use of dexamethasone in patients with high-grade glioma: a clinical practice guideline. Curr Oncol. 2014;21(3):e493.
8. Weller M, van den Bent M, Hopkins K, et al; European Association for Neuro-Oncology (EANO) Task Force on Malignant Glioma. EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. Lancet Oncol. 2014;15(9):e395-e403.
9. Mukand JA, Blackinton DD, Crincoli MG, Lee JJ, Santos BB. Incidence of neurologic deficits and rehabilitation of patients with brain tumors. Am J Phys Med Rehabil. 2001;80(5):346.
10. Sherwood PR, Given BA, Donovan H, et al. Guiding research in family care: a new approach to oncology caregiving. Psychooncology. 2008;17(10):986-996.
11. Andrewes DG, Kaye A, Murphy M, et al. Emotional and social dysfunction in patients following surgical treatment for brain tumour. J Clin Neurosci. 2003;10(4):428-433.
12. Cavers D, Hacking B, Erridge SE, Kendall M, Morris PG, Murray SA. Social, psychological and existential well-being in patients with glioma and their caregivers: a qualitative study. Can Med Assoc J. 2012;184(7):373-382.
13. Janda M, Steginga S, Dunn J, Langbecker D, Walker D, Eakin E. Unmet supportive care needs and interest in services among patients with a brain tumour and their carers. Patient Educ Couns. 2008;71(2):251-258.
14. Lucas MR. Psychosocial implications for the patient with a high-grade glioma. J Neurosci Nurs. 2010;42(2):104-108.
15. Sterckx W, Coolbrandt A, Dierckx de Casterlé B, et al. The impact of a high-grade glioma on everyday life: a systematic review from the patients and caregivers perspective. Eur J Oncol Nurs. 2013;17(1):107-117.
16. Filley CM, Kleinschmidt-DeMasters BK. Neurobehavioral presentations of brain neoplasms. West J Med. 1995;163(1):19.
17. Cummings JL. Frontal-subcortical circuits and human behavior. Arch Neurol. 1993;50(8):873-880.
18. Fuster JM. The prefrontal cortex-an update: time is of the essence. Neuron. 2001;30(2):319-333.
19. Mattavelli G, Casarotti A, Forgiarini M, Riva M, Bello L, Papagno C. Decision-making abilities in patients with frontal low-grade glioma. J Neurooncol. 2012;110(1):59-67.
20. Gregg N, Arber A, Ashkan K, et al. Neurobehavioural changes in patients following brain tumour: patients and relatives perspective. Support Care Cancer. 2014;22(11):2965-2972.
21. Irle E, Peper M, Wowra B, Kunze S. Mood changes after surgery for tumors of the cerebral cortex. Arch Neurol. 1994;51(2):164-174.
22. Campanella F, Shallice T, Ius T, Fabbro F, Skrap M. Impact of brain tumour location on emotion and personality: a voxel-based lesion-symptom mapping study on mentalization processes. Brain. 2014;137(9):2532-2545.
23. Andrewes HE, Drummond KJ, Rosenthal M, Bucknill A, Andrewes DG. Awareness of psychological and relationship problems amongst brain tumour patients and its association with carer distress. Psychooncology. 2013.
24. Dams-O'Connor K, Gordon WA. Role and impact of cognitive rehabilitation. Psychiatr Clin North Am. 2010;33(4):893-904.
25. Chambers SK, Grassi L, Hyde MK, Holland J, Dunn J. Integrating psychosocial care into neuro-oncology: challenges and strategies. Front Oncol. 2015;5:41.
26. Weitzner MA, Meyers CA, Gelke CK, Byrne KS, Levin VA, Cella DF. The functional assessment of cancer therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer. 1995;75(5):1151-1161.
27. Nelson LD, Drebing C, Satz P, Uchiyama C. Personality change in head trauma: a validity study of the Neuropsychology Behavior and Affect Profile. Arch Clin Neuropsychol. 1998;13(6):549-560.
28. Goran DA, Fabiano RJ. The scaling of the Katz Adjustment Scale in a traumatic brain injury rehabilitation sample. Brain Inj. 1993;7(3):219-229.
29. Fallowfield L, Ford S, Lewis S. No news is not good news: information preferences of patients with cancer. Psychooncology. 1995;4(3):197-202.
30. Ream E, Richardson A. The role of information in patients' adaptation to chemotherapy and radiotherapy: a review of the literature. Eur J Cancer Care. 1996;5(3):132-138.
31. Langbecker D, Janda M. Systematic review of interventions to improve the provision of information for adults with primary brain tumors and their caregivers. Front Oncol. 2015;5:1. [in press].
32. Formica V, Del Monte G, Giacchetti I, et al. Rehabilitation in neuro-oncology: a meta-analysis of published data and a mono-institutional experience. Integr Cancer Ther. 2011;10(2):119-126.
33. Fu JB, Parsons HA, Shin KY, et al. Comparison of functional outcomes in low-and high-grade astrocytoma rehabilitation inpatients. Am J Phys Med Rehabil. 2010;89(3):205-212.
34. Huang ME, Cifu DX, Keyser-Marcus L. Functional outcomes in patients with brain tumor after inpatient rehabilitation: comparison with traumatic brain injury. Am J Phys Med Rehabil. 2000;79(4):327-335.
35. Marciniak CM, Sliwa JA, Heinemann AW, Semik PE. Functional outcomes of persons with brain tumors after inpatient rehabilitation. Arch Phys Med Rehabil. 2001;82(4):457-463.
36. Roberts PS, Nuño M, Sherman D, et al. The impact of inpatient rehabilitation on function and survival of newly diagnosed patients with glioblastoma. PM R. 2014;6:514-521.
37. Tang V, Rathbone M, Dorsay JP, Jiang S, Harvey D. Rehabilitation in primary and metastatic brain tumours. J Neurol. 2008;255(6):820-827.
38. Keith RA. The functional independence measure: a new tool for rehabilitation. Adv Clin Rehabil. 1987;2:6-18.
39. Bartolo M, Zucchella C, Pace A, et al. Early rehabilitation after surgery improves functional outcome in inpatients with brain tumours. J Neurooncol. 2012;107(3):537-544.
40. Anson K, Ponsford J. Evaluation of a coping skills group following traumatic brain injury. Brain Inj. 2006;20(2):167-178.
41. Valentine AD, Passik S, Massie MJ. Psychiatric and Psychosocial Issues. Cancer in the Nervous System. 2nd ed. Oxford: University Press; 2002:572-589.
42. Anderson SI, Taylor R, Whittle IR. Mood disorders in patients after treatment for primary intracranial tumours*. Br J Neurosurg. 1999;13(5):480-485.
43. Starkstein SE, Mayberg HS, Berthier ML, et al. Mania after brain injury: neuroradiological and metabolic findings. Ann Neurol. 1990;27(6):652-659.
44. Cummings JL. Neuropsychiatric manifestations of right hemisphere lesions. Brain Lang. 1997;57(1):22-37.
45. Starkstein SE, Fedoroff P, Berthier ML, Robinson RG. Manic-depressive and pure manic states after brain lesions. Biol Psychiatry. 1991;29(2):149-158.
46. Starkweather A, Sherwood P, Lyon DE, McCain NL, Bovbjerg DH, Broaddus WC. A biobehavioral perspective on depressive symptoms in patients with a cerebral astrocytoma. J Neurosci Nurs. 2011;43(1):17.
47. Mainio A, Hakko H, Timonen M, Niemelä A, Koivukangas J, Räsänen P. Depression in relation to survival among neurosurgical patients with a primary brain tumor: a 5-year follow-up study. Neurosurgery. 2005;56(6):1234-1242.
48. Wellisch DK, Kaleita TA, Freeman D, Cloughesy T, Goldman J. Predicting major depression in brain tumor patients. Psychooncology. 2002;11(3):230-238.
49. Turjanski N, Lloyd GG. Psychiatric side-effects of medications: recent developments. Adv Psychiatr Treat. 2005;11(1):58-70.
50. Starkweather AR, Sherwood P, Lyon DE, et al. Depressive symptoms and cytokine levels in serum and tumor tissue in patients with an astrocytoma: a pilot study. BMC Res Notes. 2014;7(1):423.
51. Armstrong TS, Cohen MZ, Eriksen LR, Hickey JV. Symptom clusters in oncology patients and implications for symptom research in people with primary brain tumors. J Nurs Scholarsh. 2004;36(3):197-206.
52. Rooney AG, Carson A, Grant R. Depression in cerebral glioma patients: a systematic review of observational studies. J Natl Cancer Inst. 2011;103(1):61-76.
53. Rooney AG, McNamara S, Mackinnon M, et al. Frequency, clinical associations, and longitudinal course of major depressive disorder in adults with cerebral glioma. J Clin Oncol. 2011;29(32):4307-4312.
54. D'Angelo C, Mirijello A, Leggio L, et al. State and trait anxiety and depression in patients with primary brain tumors before and after surgery: 1-year longitudinal study. J Neurosurg. 2008;108(2):281-286.
55. Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):617.
56. Krebber AM, Buffart LM, Kleijn G, et al. Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psychooncology. 2014;23(2):121-130.
57. Brinkman TM, Liptak CC, Delaney BL, Chordas CA, Muriel AC, Manley PE. Suicide ideation in pediatric and adult survivors of childhood brain tumors. J Neurooncol. 2013;113(3):425-432.
58. Fang F, Fall K, Mittleman MA, et al. Suicide and cardiovascular death after a cancer diagnosis. N Engl J Med. 2012;366(14):1310-1318.
59. Storm HH, Christensen N, Jensen OM. Suicides among Danish patients with cancer: 1971 to 1986. Cancer. 1992;69(6):1509-1512.
60. Kendal WS. Suicide and cancer: a gender-comparative study. Ann Oncol. 2007;18(2):381-387.
61. Kendal WS, Kendal WM. Comparative risk factors for accidental and suicidal death in cancer patients. Crisis. 2012;33(6):325.
62. Fardet L, Petersen I, Nazareth I. Suicidal behavior and severe neuropsychiatric disorders following glucocorticoid therapy in primary care. Am J Psychiatry. 2012;169(5):491-497.
63. Shaw P, Mellers J, Henderson M, Polkey C, David AS, Toone BK. Schizophrenia-like psychosis arising de novo following a temporal lobectomy: timing and risk factors. J Neurol Neurosurg Psychiatry. 2004;75(7):1003-1008.
64. Singer S, Brown A, Einenkel J, et al. Identifying tumor patients' depression. Support Care Cancer. 2011;19(11):1697-1703.
65. Rooney AG, Brown PD, Reijneveld JC, Grant R. Depression in glioma: a primer for clinicians and researchers. J Neurol Neurosurg Psychiatry. 2014;85(2):230-235.
66. Fallowfield L, Ratcliffe D, Jenkins V, Saul J. Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer. 2001;84(8):1011.
67. Pelletier G, Verhoef MJ, Khatri N, Hagen N. Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J Neurooncol. 2002;57(1):41-49.
68. Mainio A, Tuunanen S, Hakko H, Niemelä A, Koivukangas J, Räsänen P. Decreased quality of life and depression as predictors for shorter survival among patients with low-grade gliomas: a follow-up from 1990 to 2003. Eur Arch Psychiatry Clin Neurosci. 2006;256(8):516-521.
69. Rooney AG, McNamara S, Mackinnon M, et al. Screening for major depressive disorder in adults with cerebral glioma: an initial validation of 3 self-report instruments. Neuro Oncol. 2013;15(1):122-129.
70. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res. 2002;52(2):69-77.
71. Kroenke K, Spitzer RL, Williams JB. The Phq-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613.
72. Beck AT, Steer RA, Brown GK. Beck Depression Inventory-II. San Antonio: 1996.
73. Pilling S, Anderson I, Goldberg D, Meader N, Taylor C. Guidelines: depression in adults, including those with a chronic physical health problem: summary of NICE guidance. BMJ. 2009;339:b4108.
74. Hart SL, Hoyt MA, Diefenbach M, et al. Meta-analysis of efficacy of interventions for elevated depressive symptoms in adults diagnosed with cancer. J Natl Cancer Inst. 2012;104(13):990-1004.
75. Cuijpers P, Sijbrandij M, Koole SL, Andersson G, Beekman AT, Reynolds CF. The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta-analysis of direct comparisons. World Psychiatry. 2013;12(2):137-148.
76. Rooney A, Grant R. Pharmacological treatment of depression in patients with a primary brain tumour. Cochrane Database Syst Rev. 2010;3:CD006932.
77. Boele FW, Klein M, Reijneveld JC, Verdonck-de Leeuw IM, Heimans JJ. Symptom management and quality of life in glioma patients. CNS Oncol. 2014;3(1):37-47.
78. Caudill JS, Brown PD, Cerhan JH, Rummans TA. Selective serotonin reuptake inhibitors, glioblastoma multiforme, and impact on toxicities and overall survival: the mayo clinic experience. Am J Clin Oncol. 2011;34(4):385-387.
79. Boele FW, Verdonck-de Leeuw IM, Cuijpers P, Reijneveld JC, Heimans JJ, Klein M. Internet-based guided self-help for glioma patients with depressive symptoms: design of a randomized controlled trial. BMC Neurol. 2014;14(1):81.
80. Bell AC, D'Zurilla TJ. Problem-solving therapy for depression: a meta-analysis. Clin Psychol Rev. 2009;29(4):348-353.
81. Bohlmeijer E, Prenger R, Taal E, Cuijpers P. The effects of mindfulness-based stress reduction therapy on mental health of adults with a chronic medical disease: a meta-analysis. J Psychosom Res. 2010;68(6):539-544.
82. Hofmann SG, Sawyer AT, Witt AA, Oh D. The effect of mindfulness-based therapy on anxiety and depression: a meta-analytic review. J Consult Clin Psychol. 2010;78(2):169.
83. Mishra SI, Scherer RW, Snyder C, Geigle PM, Berlanstein DR, Topaloglu O. Exercise interventions on health-related quality of life for people with cancer during active treatment. Cochrane Database Syst Rev. 2012;8:CD008465.
84. Galway K, Black A, Cantwell M, Cardwell CR, Mills M, Donnelly M. Psychosocial interventions to improve quality of life and emotional wellbeing for recently diagnosed cancer patients. Cochrane Database Syst Rev. 2012;11:CD007064.
85. Madhusoodanan S, Danan D, Brenner R, Bogunovic O. Brain tumor and psychiatric manifestations: a case report and brief review. Ann Clin Psychiatry. 2004;16(2):111-113.
86. Shah AH, Gordon CE, Bregy A, Shah N, Komotar RJ. Considering iatrogenic psychosis after malignant glioma resection. BMJ Case Rep. 2014;2014:bcr2013201318.
87. Karyem BH, Dunn NR, Swift RG. Psychosis after right temporal lobe tumor resection and recurrence. J Neuropsychiatry Clin Neurosci. 2015;26(1):E47.
88. Mace CJ, Trimble MR. Psychosis following temporal lobe surgery: a report of six cases. J Neurol Neurosurg Psychiatry. 1991;54(7):639-644.
89. Madhusoodanan S, Opler MG, Moise D, et al. Brain tumor location and psychiatric symptoms: is there any association? A meta-analysis of published case studies. Expert Rev Neurother. 2010;10(10):1529-1536.
90. Sokolski KN, Denson TF. Exacerbation of mania secondary to right temporal lobe astrocytoma in a bipolar patient previously stabilized on valproate. Cogn Behav Neurol. 2003;16(4):234-238.
91. Young WB, Heros DO, Ehrenberg BL, Hedges TR. Metamorphopsia and palinopsia: association with periodic lateralized epileptiform discharges in a patient with malignant astrocytoma. Arch Neurol. 1989;46(7):820-822.
92. Kanemoto K, Kawasaki J, Mori E. Postictal psychosis as a risk factor for mood disorders after temporal lobe surgery. J Neurol Neurosurg Psychiatry. 1998;65(4):587-589.
93. Trimble MR. The Psychoses of Epilepsy. Raven Press; 1991.
94. Braun CM, Dumont M, Duval J, Hamel-Hébert I, Godbout L. Brain modules of hallucination: an analysis of multiple patients with brain lesions. J Psychiatry Neurosci. 2003;28(6):432.
95. Edell WS, Tunis SL. Antipsychotic treatment of behavioral and psychological symptoms of dementia in geropsychiatric inpatients. Am J Geriatr Psychiatry. 2001;9(3):289-297.
96. Ross DA, Cetas JS. Steroid psychosis: a review for neurosurgeons. J Neurooncol. 2012;109(3):439-447.
97. Kolthof HJ. Moderne antidepressiva en hallucinaties. Tijdschr Psychiatr. 2014;56(6):407-412.
98. Sivec HJ, Montesano VL. Cognitive behavioral therapy for psychosis in clinical practice. Psychotherapy. 2012;49(2):258.
99. Wiersma D, Jenner JA, Nienhuis FJ, Willige G. Hallucination focused integrative treatment improves quality of life in schizophrenia patients. Acta Psychiatr Scand. 2004;109(3):194-201.
100. Chadwick P. Mindfulness for psychosis. Br J Psychiatry. 2014;204(5):333-334.
101. White R, Gumley A, McTaggart J, et al. A feasibility study of acceptance and commitment therapy for emotional dysfunction following psychosis. Behav Res Ther. 2011;49(12):901-907.
102. Thomas N, Hayward M, Peters E, et al. Psychological therapies for auditory hallucinations (voices): current status and key directions for future research. Schizophr Bull. 2014;40(suppl 4):S202-S212.
103. Ricciardi L, Demartini B, Fotopoulou A, Edwards MJ. Alexithymia in neurological disease: a review. J Neuropsychiatry Clin Neurosci. 2015.